Molecular Docking, Synthesis, Characterization, and Preliminary Cytotoxic evaluation of new 1, 3, 4-Thiadiazole Derivatives as Αlpha-Estrogen Receptor Modulator

Authors

  • Zainab M. Abdulkhaleq Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
  • Mohammed Hassan Mohammed Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
  • Jaafar Suhail Wadi Department of Pharmacy, AL-RAFIDAIN University College, Baghdad, Iraq.

DOI:

https://doi.org/10.22317/jcms.v8i3.1224

Keywords:

Anticancer, MCF-7, Piperidine, Methyl-piperazine, Docking study

Abstract

Objective: This study concluded that these newly synthesized analogs may be represented as an exploitable source of new anticancer agents to fight breast cancer

Methods: Using The crystal structure of Human α Estrogen Receptor (α-ER) with a 4-HYDROXYTAMOXIFEN(standard) as a co-crystalized ligand was gained from the protein data-bank (PDB code 3ERT) as a result of docking the 1,3,4-thiadiazole derivatives compounds(M1-M3) give good docking scores compared to the standard. Compounds M1-M3 was synthesized by multistep procedures from the reaction of intermediate (benzyloxy)phenyl)-1,3,4-thiadiazole-2(3H)-thione derivatives (D1, D2) and the 4-bromo-1-(cyclic amine1-yl)butan-1-one derivatives intermediate (A1, A2). The chemical structures of the target compounds and their intermediates were confirmed by FT-IR, 1H NMR, and 13C NMR.

Results: The in-vitro cytotoxicity assay (MTT assay) demonstrated that compounds M1-M3 showed good inhibition ratios in Breast cancer cell line (MCF-7) comparable with drug control Tamoxifen

Conclusion: From the docking study, it was concluded that piperidine and methyl-piperazine moiety were very successful to bind tightly to alpha estrogen receptors by making numerous interaction modes.

References

Ma X, Yu H. Global burden of cancer. Yale J Biol Med. 2006;79(3–4):85–94.

Wittekind C, Neid M. Cancer invasion and metastasis.Oncology. 2005;69(SUPPL. 1):14–6.

Wennas, O. N., Mohammed, M. H., Al Abood, R. M., & Abed, D. A. (2021). Design, Synthesis, and Biological Evaluation of Camptothecin Loaded Biotinylated Cellulose Nanowhiskers as Anticancer Agents. Journal of Contemporary Medical Sciences, 7(3), 145–151

Madeira M, Mattar A, Logullo ÂF, Soares FA, Gebrim LH. Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer. BMC Cancer. 2013;13(425).

Sharma D, Kumar S, Narasimhan B. Estrogen alpha receptor antagonists for the treatment of breast cancer: A review. Chem Cent J [Internet]. 2018;12(1):1–32. Available from: https://doi.org/10.1186/s13065-018-0472-8

Anderson H, Hills M, Zabaglo L, A’Hern R, Leary AF, Haynes BP, et al. Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer. Ann Oncol [Internet]. 2011;22(8):1770–6. Available from: https://doi.org/10.1093/annonc/mdq700

Ali R, Wendt MK, Manuscript A. Role of Epidermal Growth Factor Receptor in Breast Cancer. Signal Transduct Target Ther [Internet]. 2012;136(2):29–31. Available from: http://www.nature.com/articles/sigtrans201642

Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G,Houghton J, Locker GY, Tobias JS, et al: Results of the ATAC (Arimidex,Tamoxifen, Alone or in Combination) trial after completion of 5 years’adjuvant treatment for breast cancer. Lancet 2005, 365(9453):60–62.

Quan Jiang1, Shilong Zheng2, and Guangdi Wang*, 1, 2cript A. Development of New Estrogen Receptor-Targetting Therapic Agents. 2013;5(9):1–21.

Aronica PGA, Fox SJ, Verma CS. Comparison of Charge Derivation Methods Applied to Amino Acid Parameterization. ACS Omega. 2018;3(4):4664–73.

Hussein SAA, Kubba AARM, Abdula AM. Docking study of some new 2, 5-Disubstituted-1, 3, 4-thiadiazole derivatives against glucosamine-6-phosphate synthase. Int J Appl Chem. 2016;12(1):1–10.

Mohammadi-farani A. N -Phenyl-2- p -tolylthiazole-4-carboxamide derivatives : Syn- thesis and cytotoxicity evaluation as anticancer agents. Iran J Basic Med Sci. 2014;17:502–8.

Aliabadi AR, Harasami Neek H, Bahmani Y. 4-Halo-N-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)benzamide and Benzothioamide Derivatives: Synthesis and in vitro Anticancer Assessment. 2020;39(5):35–44.

Nimbalkar UD, Tupe SG, Vazquez JAS, Khan FAK, Sangshetti JN, Nikalje APG. Ultrasound- and molecular sieves-assisted synthesis, molecular docking and antifungal evaluation of 5-(4-(benzyloxy)-substituted phenyl)-3-((phenylamino)methyl)-1,3,4-oxadiazole-2(3h)-thiones. Molecules. 2016;21(5).

Dubey V, Pathak M, Bhat HR, Singh UP. Design, Facile Synthesis, and Antibacterial Activity of Hybrid 1,3,4-thiadiazole-1,3,5-triazine Derivatives Tethered via -S- Bridge. Chem Biol Drug Des. 2012;80(4):598–604.

Ruan X, Zhang C, Jiang S, Guo T, Xia R, Chen Y, et al. Design, synthesis, and biological activity of novel myricetin derivatives containing amide, thioether, and 1,3,4-thiadiazole moieties. Molecules. 2018;23(12):1–10.

Zhang K, Wang P, Xuan LN, Fu XY, Jing F, Li S, et al. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety. Bioorganic Med Chem Lett [Internet]. 2014;24(22):5154–6. Available from: http://dx.doi.org/10.1016/j.bmcl.2014.09.086

Deyrieux AF, Wilson VG. In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology. 2007;54(2):77–83.

Marin V, Kaplanski G, Grès S, Farnarier C, Bongrand P. Endothelial cell culture: Protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods. 2001;254(1–2):183–90.

Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, et al. Cell Viability Assays. Assay Guid Man [Internet]. 2016;1–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23805433.

Marganakop S.B., Kamble R.R., Taj T., Kariduraganvar M.Y. (2010) An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti-tubercular agents. Med Chem Res;21:185–191.

M. Bellam, M. Gundluru, S. Sarva, S. Chadive, Chem. Heterocycl. Compd., 2017, 53, 2, 173-178.

Kumar D., Kumar N.M., Chang K., Shah K. (2010) Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Eur J Med Chem;45:4664–4668.

Vasoya SL, Paghdar DJ, Chovatia PT, Joshi HS (2005) Synthesis of some new thiosemicarbazide and 1,3,4-thiadiazole heterocycles bear- ing benzo[b] thiophene nucleus as a potent antitubercular and antimi- crobial agents. J Sci, Islamic Republic of Iran 16: 33-36.

Downloads

Published

2022-06-26

How to Cite

M. Abdulkhaleq, Z. ., Hassan Mohammed, M. ., & Suhail Wadi, J. . (2022). Molecular Docking, Synthesis, Characterization, and Preliminary Cytotoxic evaluation of new 1, 3, 4-Thiadiazole Derivatives as Αlpha-Estrogen Receptor Modulator. Journal of Contemporary Medical Sciences, 8(3). https://doi.org/10.22317/jcms.v8i3.1224